To delve deeper into these ambiguities, this research utilized bioinformatics tools, like Oncomine and cBioportal, and aimed to elucidate the roles and potential prognostic value of RhoBTB3 and Col1a1 in the context of breast cancer. This evidence concerns the gene RHOBTB3 and breast carcinoma.